Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Nov;81(961):702–710. doi: 10.1136/pgmj.2005.035352

Pleural effusion

A Medford 1, N Maskell 1
PMCID: PMC1743397  PMID: 16272233

Abstract

Pleural disease remains a commonly encountered clinical problem for both general physicians and chest specialists. This review focuses on the investigation of undiagnosed pleural effusions and the management of malignant and parapneumonic effusions. New developments in this area are also discussed at the end of the review. It aims to be evidence based together with some practical suggestions for practising clinicians.

Full Text

The Full Text of this article is available as a PDF (197.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams R. F., Gray W., Davies R. J., Gleeson F. V. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001 Dec;120(6):1798–1802. doi: 10.1378/chest.120.6.1798. [DOI] [PubMed] [Google Scholar]
  2. Afessa B. Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the Pulmonary Complications, ICU support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000 Apr;117(4):1031–1037. doi: 10.1378/chest.117.4.1031. [DOI] [PubMed] [Google Scholar]
  3. Afessa B. Pleural effusions and pneumothoraces in AIDS. Curr Opin Pulm Med. 2001 Jul;7(4):202–209. doi: 10.1097/00063198-200107000-00007. [DOI] [PubMed] [Google Scholar]
  4. Ansari T., Idell S. Management of undiagnosed persistent pleural effusions. Clin Chest Med. 1998 Jun;19(2):407–417. doi: 10.1016/s0272-5231(05)70087-3. [DOI] [PubMed] [Google Scholar]
  5. Antony V. B. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie. 1999 Oct;53(10):493–498. doi: 10.1055/s-1999-9040. [DOI] [PubMed] [Google Scholar]
  6. Aquino S. L., Webb W. R., Gushiken B. J. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology. 1994 Sep;192(3):803–808. doi: 10.1148/radiology.192.3.8058951. [DOI] [PubMed] [Google Scholar]
  7. Ashbaugh D. G. Empyema thoracis. Factors influencing morbidity and mortality. Chest. 1991 May;99(5):1162–1165. doi: 10.1378/chest.99.5.1162. [DOI] [PubMed] [Google Scholar]
  8. Bartlett J. G. Antibiotics in lung abscess. Semin Respir Infect. 1991 Jun;6(2):103–111. [PubMed] [Google Scholar]
  9. Berglin E., Ekroth R., Teger-Nilsson A. C., William-Olsson G. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg. 1981 Apr;29(2):124–126. doi: 10.1055/s-2007-1023459. [DOI] [PubMed] [Google Scholar]
  10. Blackmore C. C., Black W. C., Dallas R. V., Crow H. C. Pleural fluid volume estimation: a chest radiograph prediction rule. Acad Radiol. 1996 Feb;3(2):103–109. doi: 10.1016/s1076-6332(05)80373-3. [DOI] [PubMed] [Google Scholar]
  11. Bouros D., Schiza S., Tzanakis N., Chalkiadakis G., Drositis J., Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999 Jan;159(1):37–42. doi: 10.1164/ajrccm.159.1.9803094. [DOI] [PubMed] [Google Scholar]
  12. Boutin C., Rey F., Viallat J. R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758. doi: 10.1378/chest.108.3.754. [DOI] [PubMed] [Google Scholar]
  13. Brown R. W., Clark G. M., Tandon A. K., Allred D. C. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993 Apr;24(4):347–354. doi: 10.1016/0046-8177(93)90080-z. [DOI] [PubMed] [Google Scholar]
  14. Burgess L. J., Maritz F. J., Le Roux I., Taljaard J. J. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax. 1995 Jun;50(6):672–674. doi: 10.1136/thx.50.6.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cham C. W., Haq S. M., Rahamim J. Empyema thoracis: a problem with late referral? Thorax. 1993 Sep;48(9):925–927. doi: 10.1136/thx.48.9.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chang S. C., Perng R. P. The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions. Arch Intern Med. 1989 Apr;149(4):855–857. [PubMed] [Google Scholar]
  17. Chernow B., Sahn S. A. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977 Nov;63(5):695–702. doi: 10.1016/0002-9343(77)90154-1. [DOI] [PubMed] [Google Scholar]
  18. Chetty K. G. Transudative pleural effusions. Clin Chest Med. 1985 Mar;6(1):49–54. [PubMed] [Google Scholar]
  19. Clementsen P., Evald T., Grode G., Hansen M., Krag Jacobsen G., Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med. 1998 Mar;92(3):593–596. doi: 10.1016/s0954-6111(98)90315-8. [DOI] [PubMed] [Google Scholar]
  20. Davies C. W., Kearney S. E., Gleeson F. V., Davies R. J. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1682–1687. doi: 10.1164/ajrccm.160.5.9903002. [DOI] [PubMed] [Google Scholar]
  21. Davies C. W., Lok S., Davies R. J. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998 Jan;157(1):328–330. doi: 10.1164/ajrccm.157.1.97-03094. [DOI] [PubMed] [Google Scholar]
  22. Davies C. W., Traill Z. C., Gleeson F. V., Davies R. J. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest. 1999 Mar;115(3):729–733. doi: 10.1378/chest.115.3.729. [DOI] [PubMed] [Google Scholar]
  23. Davies R. J., Traill Z. C., Gleeson F. V. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997 May;52(5):416–421. doi: 10.1136/thx.52.5.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dekker A., Bupp P. A. Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol. 1978 Dec;70(6):855–860. doi: 10.1093/ajcp/70.6.855. [DOI] [PubMed] [Google Scholar]
  25. DiBonito L., Falconieri G., Colautti I., Bonifacio D., Dudine S. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol. 1992 May-Jun;36(3):329–332. [PubMed] [Google Scholar]
  26. Dryzer S. R., Allen M. L., Strange C., Sahn S. A. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest. 1993 Dec;104(6):1763–1766. doi: 10.1378/chest.104.6.1763. [DOI] [PubMed] [Google Scholar]
  27. Eibenberger K. L., Dock W. I., Ammann M. E., Dorffner R., Hörmann M. F., Grabenwöger F. Quantification of pleural effusions: sonography versus radiography. Radiology. 1994 Jun;191(3):681–684. doi: 10.1148/radiology.191.3.8184046. [DOI] [PubMed] [Google Scholar]
  28. Epler G. R., McLoud T. C., Gaensler E. A. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982 Feb 5;247(5):617–622. [PubMed] [Google Scholar]
  29. Evans T. R., Stein R. C., Pepper J. R., Gazet J. C., Ford H. T., Coombes R. C. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer. 1993;29A(3):316–319. doi: 10.1016/0959-8049(93)90375-p. [DOI] [PubMed] [Google Scholar]
  30. Ferrara Napoleone, Gerber Hans-Peter, LeCouter Jennifer. The biology of VEGF and its receptors. Nat Med. 2003 Jun;9(6):669–676. doi: 10.1038/nm0603-669. [DOI] [PubMed] [Google Scholar]
  31. Fry W. A., Khandekar J. D. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar;2(2):160–164. doi: 10.1007/BF02303632. [DOI] [PubMed] [Google Scholar]
  32. Garcia L. W., Ducatman B. S., Wang H. H. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol. 1994 Aug;7(6):665–668. [PubMed] [Google Scholar]
  33. Gilkeson R. C., Silverman P., Haaga J. R. Using urokinase to treat malignant pleural effusions. AJR Am J Roentgenol. 1999 Sep;173(3):781–783. doi: 10.2214/ajr.173.3.10470923. [DOI] [PubMed] [Google Scholar]
  34. Good J. T., Jr, King T. E., Antony V. B., Sahn S. A. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest. 1983 Dec;84(6):714–718. doi: 10.1378/chest.84.6.714. [DOI] [PubMed] [Google Scholar]
  35. Good J. T., Jr, Taryle D. A., Maulitz R. M., Kaplan R. L., Sahn S. A. The diagnostic value of pleural fluid pH. Chest. 1980 Jul;78(1):55–59. doi: 10.1378/chest.78.1.55. [DOI] [PubMed] [Google Scholar]
  36. Grove Carolyn S., Lee Y. C. Gary. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med. 2002 Jul;8(4):294–301. doi: 10.1097/00063198-200207000-00009. [DOI] [PubMed] [Google Scholar]
  37. Hamm H., Light R. W. Parapneumonic effusion and empyema. Eur Respir J. 1997 May;10(5):1150–1156. doi: 10.1183/09031936.97.10051150. [DOI] [PubMed] [Google Scholar]
  38. Heffner J. E., Brown L. K., Barbieri C., DeLeo J. M. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995 Jun;151(6):1700–1708. doi: 10.1164/ajrccm.151.6.7767510. [DOI] [PubMed] [Google Scholar]
  39. Heffner John E. Multicenter trials of treatment for empyema--after all these years. N Engl J Med. 2005 Mar 3;352(9):926–928. doi: 10.1056/NEJMe048352. [DOI] [PubMed] [Google Scholar]
  40. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J. 1997 May;10(5):1157–1162. doi: 10.1183/09031936.97.10051157. [DOI] [PubMed] [Google Scholar]
  41. Hillerdal G., Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis. 1987 Aug;71(2):113–121. [PubMed] [Google Scholar]
  42. Hirsch A., Ruffie P., Nebut M., Bignon J., Chrétien J. Pleural effusion: laboratory tests in 300 cases. Thorax. 1979 Feb;34(1):106–112. doi: 10.1136/thx.34.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Huang H. C., Chang H. Y., Chen C. W., Lee C. H., Hsiue T. R. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest. 1999 Mar;115(3):751–756. doi: 10.1378/chest.115.3.751. [DOI] [PubMed] [Google Scholar]
  44. Hughes C. E., Van Scoy R. E. Antibiotic therapy of pleural empyema. Semin Respir Infect. 1991 Jun;6(2):94–102. [PubMed] [Google Scholar]
  45. Idell S. Evaluation of perplexing pleural effusions. Contemp Intern Med. 1994 Dec;6(12):31–39. [PubMed] [Google Scholar]
  46. Jerjes-Sánchez C., Ramirez-Rivera A., Elizalde J. J., Delgado R., Cicero R., Ibarra-Perez C., Arroliga A. C., Padua A., Portales A., Villarreal A. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest. 1996 Jun;109(6):1514–1519. doi: 10.1378/chest.109.6.1514. [DOI] [PubMed] [Google Scholar]
  47. Joseph J., Sahn S. A. Connective tissue diseases and the pleura. Chest. 1993 Jul;104(1):262–270. doi: 10.1378/chest.104.1.262. [DOI] [PubMed] [Google Scholar]
  48. Kearney S. E., Davies C. W., Davies R. J., Gleeson F. V. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol. 2000 Jul;55(7):542–547. doi: 10.1053/crad.1999.0480. [DOI] [PubMed] [Google Scholar]
  49. Kennedy L., Rusch V. W., Strange C., Ginsberg R. J., Sahn S. A. Pleurodesis using talc slurry. Chest. 1994 Aug;106(2):342–346. doi: 10.1378/chest.106.2.342. [DOI] [PubMed] [Google Scholar]
  50. Kessinger A., Wigton R. S. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol. 1987 Oct;36(2):81–83. doi: 10.1002/jso.2930360202. [DOI] [PubMed] [Google Scholar]
  51. Khare V., Baethge B., Lang S., Wolf R. E., Campbell G. D., Jr Antinuclear antibodies in pleural fluid. Chest. 1994 Sep;106(3):866–871. doi: 10.1378/chest.106.3.866. [DOI] [PubMed] [Google Scholar]
  52. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher P., Unger C., Marmé D., Gastl G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999 Jan 1;85(1):178–187. [PubMed] [Google Scholar]
  53. Kroegel C., Antony V. B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J. 1997 Oct;10(10):2411–2418. doi: 10.1183/09031936.97.10102411. [DOI] [PubMed] [Google Scholar]
  54. Lee K. A., Harvey J. C., Reich H., Beattie E. J. Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg. 1994 Jun;178(6):586–588. [PubMed] [Google Scholar]
  55. Lee Y. C. G., Lane K. B., Zoia O., Thompson P. J., Light R. W., Blackwell T. S. Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J. 2003 Aug;22(2):197–202. doi: 10.1183/09031936.03.00086202. [DOI] [PubMed] [Google Scholar]
  56. Lee Y. C. Gary, Yasay Justin R., Johnson Joyce E., Parker Richard E., Thompson Philip J., Lane Kirk B., Light Richard W. Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology. 2002 Sep;7(3):209–216. doi: 10.1046/j.1440-1843.2002.00397.x. [DOI] [PubMed] [Google Scholar]
  57. Lesho E. P., Roth B. J. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH? Chest. 1997 Nov 5;112(5):1291–1292. doi: 10.1378/chest.112.5.1291. [DOI] [PubMed] [Google Scholar]
  58. Leung A. N., Müller N. L., Miller R. R. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990 Mar;154(3):487–492. doi: 10.2214/ajr.154.3.2106209. [DOI] [PubMed] [Google Scholar]
  59. Light R. W. Diagnostic principles in pleural disease. Eur Respir J. 1997 Feb;10(2):476–481. doi: 10.1183/09031936.97.10020476. [DOI] [PubMed] [Google Scholar]
  60. Light R. W., Erozan Y. S., Ball W. C., Jr Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med. 1973 Dec;132(6):854–860. [PubMed] [Google Scholar]
  61. Light R. W., Girard W. M., Jenkinson S. G., George R. B. Parapneumonic effusions. Am J Med. 1980 Oct;69(4):507–512. doi: 10.1016/0002-9343(80)90460-x. [DOI] [PubMed] [Google Scholar]
  62. Light R. W., Macgregor M. I., Luchsinger P. C., Ball W. C., Jr Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972 Oct;77(4):507–513. doi: 10.7326/0003-4819-77-4-507. [DOI] [PubMed] [Google Scholar]
  63. Light R. W., Nguyen T., Mulligan M. E., Sasse S. A. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung. 2000;178(1):13–18. doi: 10.1007/s004080000002. [DOI] [PubMed] [Google Scholar]
  64. Light R. W., Rogers J. T., Cheng D., Rodriguez R. M. Large pleural effusions occurring after coronary artery bypass grafting. Cardiovascular Surgery Associates, PC. Ann Intern Med. 1999 Jun 1;130(11):891–896. doi: 10.7326/0003-4819-130-11-199906010-00004. [DOI] [PubMed] [Google Scholar]
  65. Loddenkemper R. Thoracoscopy--state of the art. Eur Respir J. 1998 Jan;11(1):213–221. doi: 10.1183/09031936.98.11010213. [DOI] [PubMed] [Google Scholar]
  66. Maher G. G., Berger H. W. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis. 1972 Mar;105(3):458–460. doi: 10.1164/arrd.1972.105.3.458. [DOI] [PubMed] [Google Scholar]
  67. Maskell N. A., Gleeson F. V., Davies R. J. O. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet. 2003 Apr 19;361(9366):1326–1330. doi: 10.1016/s0140-6736(03)13079-6. [DOI] [PubMed] [Google Scholar]
  68. Maskell Nick A., Gleeson Fergus V., Darby Mike, Davies Robert J. O. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest. 2004 Dec;126(6):2022–2024. doi: 10.1378/chest.126.6.2022. [DOI] [PubMed] [Google Scholar]
  69. Maskell Nick A., Lee Y. C. Gary, Gleeson Fergus V., Hedley Emma L., Pengelly Gerry, Davies Robert J. O. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004 May 13;170(4):377–382. doi: 10.1164/rccm.200311-1579OC. [DOI] [PubMed] [Google Scholar]
  70. Miller K. S., Sahn S. A. Chest tubes. Indications, technique, management and complications. Chest. 1987 Feb;91(2):258–264. doi: 10.1378/chest.91.2.258. [DOI] [PubMed] [Google Scholar]
  71. Morelock S. Y., Sahn S. A. Drugs and the pleura. Chest. 1999 Jul;116(1):212–221. doi: 10.1378/chest.116.1.212. [DOI] [PubMed] [Google Scholar]
  72. Mungall I. P., Cowen P. N., Cooke N. T., Roach T. C., Cooke N. J. Multiple pleural biopsy with the Abrams needle. Thorax. 1980 Aug;35(8):600–602. doi: 10.1136/thx.35.8.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Müller N. L. Imaging of the pleura. Radiology. 1993 Feb;186(2):297–309. doi: 10.1148/radiology.186.2.8421723. [DOI] [PubMed] [Google Scholar]
  74. Naidich D. P., Lee J. J., Garay S. M., McCauley D. I., Aranda C. P., Boyd A. D. Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. AJR Am J Roentgenol. 1987 Jan;148(1):1–7. doi: 10.2214/ajr.148.1.1. [DOI] [PubMed] [Google Scholar]
  75. Negrini D., Pistolesi M., Miniati M., Bellina R., Giuntini C., Miserocchi G. Regional protein absorption rates from the pleural cavity in dogs. J Appl Physiol (1985) 1985 Jun;58(6):2062–2067. doi: 10.1152/jappl.1985.58.6.2062. [DOI] [PubMed] [Google Scholar]
  76. Neild J. E., Eykyn S. J., Phillips I. Lung abscess and empyema. Q J Med. 1985 Dec;57(224):875–882. [PubMed] [Google Scholar]
  77. Parker L. A., Charnock G. C., Delany D. J. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer. 1989 Sep 15;64(6):1218–1221. doi: 10.1002/1097-0142(19890915)64:6<1218::aid-cncr2820640609>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  78. Peters R. M. Empyema thoracis: historical perspective. Ann Thorac Surg. 1989 Aug;48(2):306–308. doi: 10.1016/0003-4975(89)90100-8. [DOI] [PubMed] [Google Scholar]
  79. Pettersson T., Klockars M., Hellström P. E. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax. 1982 May;37(5):354–361. doi: 10.1136/thx.37.5.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Prakash U. B., Reiman H. M. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc. 1985 Mar;60(3):158–164. doi: 10.1016/s0025-6196(12)60212-2. [DOI] [PubMed] [Google Scholar]
  81. Pulsiripunya C., Youngchaiyud P., Pushpakom R., Maranetra N., Nana A., Charoenratanakul S. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology. 1996 Mar;1(1):69–72. doi: 10.1111/j.1440-1843.1996.tb00013.x. [DOI] [PubMed] [Google Scholar]
  82. Putnam J. B., Jr, Walsh G. L., Swisher S. G., Roth J. A., Suell D. M., Vaporciyan A. A., Smythe W. R., Merriman K. W., DeFord L. L. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000 Feb;69(2):369–375. doi: 10.1016/s0003-4975(99)01482-4. [DOI] [PubMed] [Google Scholar]
  83. Renshaw A. A., Dean B. R., Antman K. H., Sugarbaker D. J., Cibas E. S. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997 Jan;111(1):106–109. doi: 10.1378/chest.111.1.106. [DOI] [PubMed] [Google Scholar]
  84. Robinson Bruce W. S., Creaney Jenette, Lake Richard, Nowak Anna, Musk A. William, de Klerk Nick, Winzell Pernilla, Hellstrom Karl Erik, Hellstrom Ingegerd. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003 Nov 15;362(9396):1612–1616. doi: 10.1016/S0140-6736(03)14794-0. [DOI] [PubMed] [Google Scholar]
  85. Ruskin J. A., Gurney J. W., Thorsen M. K., Goodman L. R. Detection of pleural effusions on supine chest radiographs. AJR Am J Roentgenol. 1987 Apr;148(4):681–683. doi: 10.2214/ajr.148.4.681. [DOI] [PubMed] [Google Scholar]
  86. Sahn S. A., Good J. T., Jr Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med. 1988 Mar;108(3):345–349. doi: 10.7326/0003-4819-108-3-345. [DOI] [PubMed] [Google Scholar]
  87. Sherman S., Grady K. J., Seidman J. C. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J. 1987 Jun;80(6):716–719. doi: 10.1097/00007611-198706000-00013. [DOI] [PubMed] [Google Scholar]
  88. Silverman S. G., Mueller P. R., Saini S., Hahn P. F., Simeone J. F., Forman B. H., Steiner E., Ferrucci J. T. Thoracic empyema: management with image-guided catheter drainage. Radiology. 1988 Oct;169(1):5–9. doi: 10.1148/radiology.169.1.3047789. [DOI] [PubMed] [Google Scholar]
  89. Storm H. K., Krasnik M., Bang K., Frimodt-Møller N. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax. 1992 Oct;47(10):821–824. doi: 10.1136/thx.47.10.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Sørensen P. G., Svendsen T. L., Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis. 1984 Feb;65(2):131–135. [PubMed] [Google Scholar]
  91. Tarver R. D., Broderick L. S., Conces D. J., Jr Reexpansion pulmonary edema. J Thorac Imaging. 1996 Summer;11(3):198–209. [PubMed] [Google Scholar]
  92. Thomson A. H., Hull J., Kumar M. R., Wallis C., Balfour Lynn I. M. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002 Apr;57(4):343–347. doi: 10.1136/thorax.57.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Tillett W. S., Sherry S. THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS. J Clin Invest. 1949 Jan;28(1):173–190. doi: 10.1172/JCI102046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Traill Z. C., Davies R. J., Gleeson F. V. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol. 2001 Mar;56(3):193–196. doi: 10.1053/crad.2000.0573. [DOI] [PubMed] [Google Scholar]
  95. Turton C. W. Troublesome pleural fluid. Br J Dis Chest. 1987 Jul;81(3):217–224. doi: 10.1016/0007-0971(87)90153-7. [DOI] [PubMed] [Google Scholar]
  96. Villanueva A. G., Gray A. W., Jr, Shahian D. M., Williamson W. A., Beamis J. F., Jr Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax. 1994 Jan;49(1):23–25. doi: 10.1136/thx.49.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Waller D. A., Morritt G. N., Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995 May;107(5):1454–1456. doi: 10.1378/chest.107.5.1454. [DOI] [PubMed] [Google Scholar]
  98. Wooten S. A., Barbarash R. A., Strange C., Sahn S. A. Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest. 1988 Nov;94(5):960–963. doi: 10.1378/chest.94.5.960. [DOI] [PubMed] [Google Scholar]
  99. Xie C., Teixeira L. R., McGovern J. P., Light R. W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1441–1444. doi: 10.1164/ajrccm.157.5.9708032. [DOI] [PubMed] [Google Scholar]
  100. Yang P. C., Luh K. T., Chang D. B., Wu H. D., Yu C. J., Kuo S. H. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol. 1992 Jul;159(1):29–33. doi: 10.2214/ajr.159.1.1609716. [DOI] [PubMed] [Google Scholar]
  101. Yim A. P., Chung S. S., Lee T. W., Lam C. K., Ho J. K. Thoracoscopic management of malignant pleural effusions. Chest. 1996 May;109(5):1234–1238. doi: 10.1378/chest.109.5.1234. [DOI] [PubMed] [Google Scholar]
  102. Yung R. L., Johnson K. J., Richardson B. C. New concepts in the pathogenesis of drug-induced lupus. Lab Invest. 1995 Dec;73(6):746–759. [PubMed] [Google Scholar]
  103. Zimmer P. W., Hill M., Casey K., Harvey E., Low D. E. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest. 1997 Aug;112(2):430–434. doi: 10.1378/chest.112.2.430. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES